mRNA Vaccines, Blood Tests Signal a Cancer Turning Point
Personalized mRNA cancer vaccines, multi-cancer early detection blood tests, and two newly approved leukemia drugs are converging in 2026 to usher in a new era of precision oncology, with Dana-Farber analysts calling it the densest concentration of breakthroughs in twenty years.